Cryptococcosis in systemic lupus erythematosus: A series of six cases

Lupus

Volumn 19, Issue 5, 2010, Pages 639-645

  Gonzalez L A ^a   Vasquez G ^a   Restrepo, J P ^a   Velasquez M ^a   Ramirez L A ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Cryptococcosis; Cryptococcus; Opportunistic infection; Systemic Lupus Erythematosus

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; FLUCONAZOLE; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD CULTURE; CAUSE OF DEATH; CELLULAR IMMUNITY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LATEX AGGLUTINATION TEST; MALE; MEDICAL ASSESSMENT; ONSET AGE; PRIORITY JOURNAL; PULMONARY CRYPTOCOCCOSIS; RELAPSE; RETROSPECTIVE STUDY; SEROLOGY; SPUTUM CULTURE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CRYPTOCOCCOSIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77951225215     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309356458     Document Type: Article

References (15)

1. Juarez M., Misischia R., Alarcón GS Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin North Am 2003 ; 29: 163-184. (Pubitemid 36298109)
2. Duffy KN, Duffy CM, Gladman DD Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 1991 ; 18: 1180-1184.
3. Petri M., Genovese M. Incidence and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins lupus cohort. J Rheumatol 1992 ; 19: 1559-1565.
4. Fessler BJ Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002 ; 16: 281-291. (Pubitemid 36526644)
5. Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology 2007 ; 46: 539-544.
6. Hung J-J., Ou L-S., Lee W-I., Huang J-L. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005 ; 32: 40-43. (Pubitemid 40092588)
7. Zimmermann B. III, Spiegel M., Lally EV Cryptococcal meningitis in systemic lupus erythematosus. Semin Arthritis Rheum 1992 ; 22: 18-24.
8. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH the Committee on Prognosis Studies in SLE. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992 ; 35: 630-640.
9. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369. (Pubitemid 26085211)
10. Churg J., Sobin LH Renal Disease: Classification and Atlas of Glomerular Diseases. New York: IGAKU-SHOIN; 1982. p. 127-149.
11. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin N Am 2002 ; 16: 837-834. (Pubitemid 35477516)
12. Lionakis MS, Kontoyiannis DP Glucocorticoids and invasive fungal infections. Lancet 2003 ; 362: 1828-1838.
13. Mok CC, Lau CS, Yuen KY Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus. Clin Exp Rheumatol 1998 ; 16: 169-171. (Pubitemid 28241572)
14. Casadevall A., Rosas AL, Nosanchuk JD Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 2000 ; 3: 354-358. (Pubitemid 30640358)
15. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000 ; 30: 710-771.